antonio pagliuca

King's College London

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

20%

Immunology

20%

Covid-19 Epidemiology

30%

Sars-cov-2

30%

Antiviral Therapy

30%

Hematology

20%

Covid-19 Diagnosis

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens

Article Link

Year:

2024

Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID‐19 in immunocompromised patients

Article Link

Year:

2023

Foreword

Article Link

Year:

2022

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

Article Link

Year:

2021

Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients.

Article Link

Year:

2020

Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases

Article Link

Year:

2020

Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)

Article Link

Year:

2020

Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients

Article Link

Year:

2020

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

Article Link

Year:

2020

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group

Article Link

Year:

2020

Collaborators6

Francesco Passamonti

ITALY

Lennard Lee

Associate Professor

University of Oxford

UNITED KINGDOM

Jan Novak

CZECH REPUBLIC

B. Deau

FRANCE

Jean Mbisa

Head, Antiviral Unit

UNITED KINGDOM

Isabel Regalado-Artamendi

Instituto de Investigación Sanitaria Gregorio Marañón

SPAIN

How do I reach out?

Meet Kite AI